Editorial: risk of gastric and duodenal ulcers among new users of low-dose aspirin
- PMID: 35748847
- DOI: 10.1111/apt.17062
Editorial: risk of gastric and duodenal ulcers among new users of low-dose aspirin
Comment on
-
Strongly increased risk of gastric and duodenal ulcers among new users of low-dose aspirin: results from two large cohorts with new-user design.Aliment Pharmacol Ther. 2022 Jul;56(2):251-262. doi: 10.1111/apt.17050. Epub 2022 May 27. Aliment Pharmacol Ther. 2022. PMID: 35621052
References
REFERENCES
-
- Nguyen TNM, Sha S, Chen L-J, Holleczek B, Brenner H, Schöttker B. Strongly increased risk of gastric and duodenal ulcers among new users of low-dose aspirin: results from two large cohorts with new-user design. Aliment Pharmacol Ther. 2022;56:251-262.
-
- Humphrey LL, Chan BKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002;137:273-84.
-
- Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158:915-20.
-
- St John DJB, Yeomans ND, McDermott FT, De Boer WGRM. Adaptation of the gastric mucosa to repeated administration of aspirin in the rat. Am J Dig Dis. 1973;18:881-6.
-
- Alderman BM, Ulaganathan M, Judd LM, Howlett M, Parker LM, Yeomans ND, et al. Insights into the mechanisms of gastric adaptation to aspirin-induced injury: a role for regenerating protein but not trefoil peptides. Lab Invest. 2003;83:1415-25.